Camingao, Jora Mae P.

HRN: 29-02-18  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2026
CO-AMOXICLAV 625MG (TAB)
05/18/2026
05/25/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE; UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractReproductive Tract    Compliance to guidelines: Compliant To Guidelines